SPYRE THERAPEUTICS, INC. (SYRE) Pre-Tax Margin
- 2023-06-30: Pre-Tax Margin -31551.45%.
- 2023-03-31: Pre-Tax Margin -9322.22%.
- 2022-12-31: Pre-Tax Margin -11180.95%.
- 2022-09-30: Pre-Tax Margin -10599.43%.
Complete source-backed pre-tax margin history.
- Available history
- 2021-06-30 to 2023-12-31
- Data captured
Historical Pre-Tax Margin
| Date | Pre-Tax Margin |
|---|---|
| 2023-06-30 | -31551.45% |
| 2023-03-31 | -9322.22% |
| 2022-12-31 | -11180.95% |
| 2022-09-30 | -10599.43% |
| 2022-06-30 | -3570.24% |
| 2022-03-31 | -1794.13% |
| 2021-12-31 | -560.46% |
| 2021-09-30 | -1449.68% |
| 2021-06-30 | -49.20% |
Annual Pre-Tax Margin
| Date | Pre-Tax Margin |
|---|---|
| 2023-12-31 | -38241.08% |
| 2022-12-31 | -3604.59% |
| 2021-12-31 | -350.39% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |